×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| NGL FINE-CHEM LTD. | 889.67 | 12.77 | 890.99 | 2.07 | 682.0 | 20.9 |
| WANBURY LTD. | 1342.89 | 12.18 | 1334.52 | 0.35 | 668 | 36.4 |
| Bharat Parenterals Limited | 752.10 | -78.70 | 722.60 | -10.00 | 660 | 24.2 |
NGL Fine Chem Ltd., with Security Code 524774, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 62.9 | 64.9 | 69.7 | 72.9 | 69.1 | 79.4 | 84.8 | 95.6 | 88.0 | 91.4 |
| Expenses | 63.5 | 60.2 | 62.4 | 62.3 | 61.5 | 66.3 | 73.9 | 83.0 | 81.7 | 80.8 |
| Operating Profit | -0.5 | 4.8 | 7.4 | 10.6 | 7.6 | 13.1 | 11.0 | 12.6 | 6.3 | 10.6 |
| OPM % | -0.83% | 7.31% | 10.64% | 14.58% | 11% | 16.53% | 12.91% | 13.18% | 7.18% | 11.62% |
| Other Income | 3.6 | 4.1 | 3.0 | 2.7 | 3.8 | 3.8 | 4.2 | 4.2 | 6.3 | 5.4 |
| Interest | 0.5 | 0.1 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.5 | 0.4 | 0.3 |
| Depreciation | 2.0 | 2.0 | 2.0 | 1.9 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.3 |
| Profit before tax | 0.7 | 6.7 | 8.1 | 11.1 | 9.2 | 14.5 | 12.8 | 14.2 | 10.0 | 13.4 |
| Tax % | 23.3% | 26% | 25% | 23% | 14.8% | 24.4% | 30.5% | 23.8% | 21.8% | 25.2% |
| Net Profit | 0.5 | 5.0 | 6.1 | 8.5 | 7.8 | 11.0 | 8.9 | 10.8 | 7.8 | 10.0 |
| EPS in Rs | 0.83 | 8.03 | 9.86 | 13.81 | 12.63 | 17.76 | 14.4 | 17.56 | 12.67 | 16.26 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67.7 | 71.9 | 73.9 | 71.0 | 80.2 | 88.0 | 99.8 | 90.8 | 93.5 | 89.1 |
| Expenses | 58.6 | 62.1 | 60.9 | 61.2 | 66.2 | 74.1 | 83.9 | 81.4 | 81.9 | 84.0 |
| Operating Profit | 9.1 | 9.8 | 13.0 | 9.9 | 14.0 | 13.9 | 15.8 | 9.4 | 11.6 | 5.1 |
| OPM % | 13.5% | 13.6% | 17.6% | 13.9% | 17.4% | 15.8% | 15.9% | 10.3% | 12.4% | 5.7% |
| Other Income | 0.5 | 0.7 | 2.1 | 3.3 | 3.2 | 3.7 | 3.7 | 5.9 | 5.1 | -0.1 |
| Interest | 0.1 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.5 | 0.4 | 0.3 | 0.6 |
| Depreciation | 3.2 | 1.2 | 2.7 | 2.9 | 2.9 | 2.9 | 2.9 | 3.0 | 3.0 | 3.1 |
| Profit before tax | 6.3 | 9.0 | 12.1 | 10.1 | 13.9 | 14.3 | 16.1 | 11.8 | 13.3 | 1.3 |
| Tax % | 25.4% | 28% | 22.6% | 15.6% | 24.8% | 30% | 23.4% | 21.8% | 26.4% | 0.9% |
| Net Profit | 4.7 | 6.5 | 9.3 | 8.5 | 10.5 | 10.0 | 12.3 | 9.2 | 9.8 | 1.3 |
| EPS in Rs | 7 | 10 | 15 | 13 | 16 | 16 | 19 | 14 | 15 | 2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 8% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | -11% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 20% |
| 3 Years: | -20% |
| 1 Year: | -50% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 10% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | -10% |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 20% |
| 3 Years: | -20% |
| 1 Year: | -50% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|